NCT00004311View on ClinicalTrials.gov

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1989

Study Completion Date

January 31, 1996

Conditions
Acanthosis NigricansPolycystic Ovary Syndrome
Interventions
DRUG

leuprolide acetate

DRUG

spironolactone

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

National Center for Research Resources (NCRR)

NIH